UNSPSC 51111866: Sulprostone

This classification denotes a prostaglandin analogue with the molecular formula C23H31NO7S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 501Q5EQ1GM, chemically known as 16-phenoxy-omega-17,18,19,20-tetranor prostaglandin e2 methylsulfonylamide but generally known as sulprostone, which bears US NIH Compound Identifier 5312153. European Medicines Agency schedules Sulprostone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10760MIG.

UNSPSC 51111866 Sulprostone is a Commodity code covering pharmaceutical products supplied through state and local cooperative purchasing arrangements. State and local governments procure generic multi-source pharmaceuticals and over-the-counter products under this code through established wholesaler networks, with vendors required to maintain cGMP certification, Drug Supply Chain Security Act compliance, and contractual relationships with authorized distributors. The work involves establishing supply agreements for identified pharmaceutical products with specific National Drug Codes, pricing submissions across multiple format options (flat price, net price variants, or WAC-minus structures), and compliance with administrative data formatting, EDI capability, and performance penalty structures tied to reporting and onboarding timelines.

The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration's Office of State Procurement, represents the primary recent issuing body under this code. MMCAP's January 2026 RFP for generic multi-source pharmaceuticals and OTC products—due March 26, 2026, with questions closing February 18, 2026—solicits manufacturers to supply participating state and local government facilities across Minnesota and Oregon through three authorized wholesalers: AmerisourceBergen Drug Corporation (Cencora), Cardinal Health 110 and 112, and Morris & Dickson Co., LLC. Awarded vendors face a two-year initial contract term effective July 1, 2026, with optional extensions at MMCAP's discretion, evaluation weighted 75 percent on price competitiveness, 10 percent on fixed pricing compliance, and 5 percent each on administrative format compliance, EDI capability, and agreement to a 3 percent administrative fee. Vendors must carry commercial general liability of $5,000,000 per occurrence, network security and privacy liability of $2,000,000, and professional liability of $2,000,000.